About ImmGenics Pharmaceuticals
ImmGenics Pharmaceuticals is a Healthcare company based in Vancouver (Canada) founded in 1993, and was acquired by Abgenix in September 2000. Technology for antibody drug discovery. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
ImmGenics Pharmaceuticals was founded in 1993 in Vancouver, Canada, within the biotechnology sector. A proprietary lymphocyte antibody technology was created, by which B-cells are cultured directly and assayed over several days via a microplate-based throughput system. Greater numbers of antibodies can be screened for specific antigen targets as a result. Operations centered on advancing drug discovery processes until acquisition by Abgenix in November 2000.
- Headquarters Vancouver, Canada
- Stage Acquired
- SectorsHealthcare
- Website immgenics.com
- Acquired by Abgenix (Sep 2000)
Funding Insights of ImmGenics Pharmaceuticals
- Total Rounds 1
- Last Round Post-IPO — $6M
- First Round $6M
(May 2000)
- Investors Count 1
All 1 funding rounds of ImmGenics Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2000 | $6M | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in ImmGenics Pharmaceuticals
ImmGenics Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Nomura and Abgenix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified asset management services are offered globally by the firm. | 1925 | nomura.com | Chuo City, Japan | |
Fully human therapeutic antibodies for cancer and inflammation are discovered. | 1996 | abgenix.com | Fremont, United States |
Investor details for ImmGenics Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ImmGenics Pharmaceuticals
3 dated milestones of ImmGenics Pharmaceuticals across 7 years, from founding to its latest funding, stage changes and deals.
- Founded ImmGenics Pharmaceuticals is founded.
- Funding First funding round of $6.0M.
- Exit Acquired by Abgenix.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ImmGenics Pharmaceuticals
ImmGenics Pharmaceuticals was founded in 1993 and raised its 1st funding round 7 years after it was founded.
ImmGenics Pharmaceuticals is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
ImmGenics Pharmaceuticals was founded in 1993 in Vancouver, Canada, within the biotechnology sector. A proprietary lymphocyte antibody technology was created, by which B-cells are cultured directly and assayed over several days via a microplate-based throughput system. Greater numbers of antibodies can be screened for specific antigen targets as a result. Operations centered on advancing drug discovery processes until acquisition by Abgenix in November 2000.
Yes. ImmGenics Pharmaceuticals was acquired by Abgenix in September 2000.